Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agents from three novel drug classes showed safety and hints of efficacy in patients with varying stages of chronic kidney disease in three phase 2 studies at the European Renal Association Congress.
/PRNewswire/ -- A new study published in The Journal of Vascular Access (JVA) examines several important metrics that describe the performance of the ivWatch...
Published in The Journal of Vascular Access (JVA), study shows company's patented patient monitoring system detects IV infiltrations and extravasa...
Contrary to current conventional wisdom, patients with chronic kidney disease who develop mild or moderate acute kidney injury have only a small subsequent worsening of kidney function.
/PRNewswire/ -- Peripheral intravenous catheter (PIVC) insertion in a patient is the most frequently performed invasive procedure with up to 90% of those...